86 related articles for article (PubMed ID: 22198373)
1. Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia.
Crisafulli C; Chiesa A; Han C; Lee SJ; Shim DS; Balzarro B; Andrisano C; Sidoti A; Patkar AA; Pae CU; Serretti A
Neurosci Lett; 2012 Feb; 508(1):37-41. PubMed ID: 22198373
[TBL] [Abstract][Full Text] [Related]
2. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
[TBL] [Abstract][Full Text] [Related]
3. Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.
Crisafulli C; Chiesa A; De Ronchi D; Han C; Lee SJ; Park MH; Patkar AA; Pae CU; Serretti A
Neurosci Lett; 2012 Jan; 506(1):170-4. PubMed ID: 22094384
[TBL] [Abstract][Full Text] [Related]
4. Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics.
Crisafulli C; Chiesa A; Han C; Lee SJ; Park MH; Balzarro B; Andrisano C; Patkar AA; Pae CU; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2012 Apr; 262(3):199-205. PubMed ID: 22120873
[TBL] [Abstract][Full Text] [Related]
5. DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes.
Chiesa A; Pae CU; Porcelli S; Han C; Lee SJ; Patkar AA; Park MH; Serretti A
Int J Psychiatry Clin Pract; 2011 Nov; 15(4):303-10. PubMed ID: 22122005
[TBL] [Abstract][Full Text] [Related]
6. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
Serretti A; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Pae CU
Psychiatry Res; 2011 Aug; 189(1):26-32. PubMed ID: 21396719
[TBL] [Abstract][Full Text] [Related]
7. The influence of AHI1 variants on the diagnosis and treatment outcome in schizophrenia.
Porcelli S; Pae CU; Han C; Lee SJ; Patkar AA; Masand PS; Balzarro B; Alberti S; De Ronchi D; Serretti A
Int J Mol Sci; 2015 Jan; 16(2):2517-29. PubMed ID: 25622261
[TBL] [Abstract][Full Text] [Related]
8. Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
Pae CU; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Serretti A; De Ronchi D
Neuropsychobiology; 2012; 65(1):1-11. PubMed ID: 22094229
[TBL] [Abstract][Full Text] [Related]
9. A polymorphism of the CREB binding protein (CREBBP) gene is a risk factor for addiction.
Kumar D; Deb I; Chakraborty J; Mukhopadhyay S; Das S
Brain Res; 2011 Aug; 1406():59-64. PubMed ID: 21752352
[TBL] [Abstract][Full Text] [Related]
10. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.
Schuhmacher A; Becker T; Rujescu D; Quednow BB; Lennertz L; Wagner M; Benninghoff J; Rietschel M; Häfner H; Franke P; Wölwer W; Gaebel W; Maier W; Mössner R
J Psychiatr Res; 2012 Aug; 46(8):1073-80. PubMed ID: 22655589
[TBL] [Abstract][Full Text] [Related]
11. Gene expression meta-analysis reveals the up-regulation of CREB1 and CREBBP in Brodmann Area 10 of patients with schizophrenia.
Ohayon S; Yitzhaky A; Hertzberg L
Psychiatry Res; 2020 Oct; 292():113311. PubMed ID: 32712449
[TBL] [Abstract][Full Text] [Related]
12. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
Molero P; Ortuño F; Zalacain M; Patiño-García A
Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
[TBL] [Abstract][Full Text] [Related]
13. CREM variant rs17583959 conferred susceptibility to T1D risk in the Tunisian families.
Zouidi F; Bouzid D; Fourati H; Fakhfakh R; Kammoun T; Hachicha M; Penha-Gonçalves C; Masmoudi H
Immunol Lett; 2017 Jan; 181():1-5. PubMed ID: 27840176
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
[TBL] [Abstract][Full Text] [Related]
15. RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Huang CH; Tsai GE
J Clin Psychopharmacol; 2008 Feb; 28(1):64-8. PubMed ID: 18204343
[TBL] [Abstract][Full Text] [Related]
16. [Association of cyclic adenosine monophosphate response element-binding protein gene and major depressive disorder].
Liu XH; Xu YF; Cui DH; Jiang SD; Qian YP; Yu SY; Jiang KD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):263-6. PubMed ID: 20533262
[TBL] [Abstract][Full Text] [Related]
17. Pleckstrin homology domain containing 6 protein (PLEKHA6) polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients.
Spellmann I; Rujescu D; Musil R; Meyerwas S; Giegling I; Genius J; Zill P; Dehning S; Cerovecki A; Seemüller F; Schennach R; Hartmann AM; Schäfer M; Müller N; Möller HJ; Riedel M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():190-5. PubMed ID: 24576533
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test.
Rafa-Zabłocka K; Kreiner G; Bagińska M; Kuśmierczyk J; Parlato R; Nalepa I
Sci Rep; 2017 Oct; 7(1):13515. PubMed ID: 29044198
[TBL] [Abstract][Full Text] [Related]
19. Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.
Carlberg L; Schosser A; Calati R; Serretti A; Massat I; Papageorgiou K; Kocabas NA; Mendlewicz J; Zohar J; Montgomery SA; Souery D; Kasper S
Int J Neurosci; 2015 May; 125(5):336-43. PubMed ID: 24955721
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the SNAP25 gene is associated with symptom improvement in schizophrenic patients treated with amisulpride.
Kang SG; Chee IS; Chang HS; Na KS; Lee K; Lee J
Neurosci Lett; 2017 Nov; 661():46-50. PubMed ID: 28947383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
